iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Phase 1 trial of CAR T-cell therapy for lymphoma
Immunotherapy for multiple myeloma: current research avenues
Current research to overcome T-cell dysfunction in CLL and improve therapies
Efficacy and safety of CD19-targeted CAR T-cells for relapsed/refractory ALL